- Investing Ideas
- /
- Swedish Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals
Swedish Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals
Results
3
0 new
High return on equity, past performance and sound balance sheet.
3 companies
BioArctic
Market Cap: SEK 27.9b
Develops biological drugs for patients with central nervous system disorders in Sweden.
BIOA B
SEK 315.40
7D
3.8%
1Y
74.9%
Saniona
Market Cap: SEK 2.9b
A clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of treatments for rare disease patients in Sweden, the United States, Germany, Denmark, and the United Kingdom.
SANION
SEK 21.30
7D
18.3%
1Y
226.2%
Cantargia
Market Cap: SEK 977.0m
A biotechnology company, develops pharmaceuticals for treatment of cancer, inflammatory, and autoimmune diseases.
CANTA
SEK 3.93
7D
-6.7%
1Y
119.4%